Comparison of tolerability and adverse symptoms in oxcarbazepine and carbamazepine in the treatment of trigeminal neuralgia and neuralgiform headaches using the Liverpool Adverse Events Profile (AEP)-Reference-Cited by-同舟云学术

Comparison of tolerability and adverse symptoms in oxcarbazepine and carbamazepine in the treatment of trigeminal neuralgia and neuralgiform headaches using the Liverpool Adverse Events Profile (AEP)

Published:2015-09-03 Issue:1 Volume:16 Page:
ISSN:1129-2369
Container-title:The Journal of Headache and Pain
language:en
Short-container-title:J Headache Pain

Author:

Besi E.,Boniface D. R.,Cregg R.,Zakrzewska J. M.

Publisher

Springer Science and Business Media LLC

Subject

Anesthesiology and Pain Medicine,Clinical Neurology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s10194-015-0563-z

Reference36 articles.

1. Saini P, Loke YK, Gamble C, Altman DG, Williamson PR, Kirkham JJ (2014) Selective reporting bias of harm outcomes within studies: findings from a cohort of systematic reviews. BMJ 349:g6501

2. Zakrzewska JM, Linskey ME (2014) Trigeminal neuralgia. BMJ 348:g474

3. Di Stefano G, La Cesa S, Truini A, Cruccu G (2014) Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain. J Headache Pain 15:34

4. Zakrzewska JM (2001) Consumer views on management of trigeminal neuralgia. Headache 41:369–376

5. Baker GA, Frances P, Middleton E (1994) Initial development, reliability, and validity of a patient-based adverse event scale. Epilepsia 35:80

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of oral sodium chloride in reducing the incidence of hyponatremia in children with epilepsy receiving oxcarbazepine monotherapy: A randomized controlled trial (SCHO Trial);Epilepsy & Behavior;2024-09

2. Nanomedicine and voltage-gated sodium channel blockers in pain management: a game changer or a lost cause?;Drug Delivery and Translational Research;2024-06-11

3. Trigeminal and Glossopharyngeal Neuralgia;Neurologic Clinics;2024-05

4. Compared to oxcarbazepine and carbamazepine, botulinum toxin type A is a useful therapeutic option for trigeminal neuralgia symptoms: A systematic review;Clinical and Experimental Dental Research;2024-03-31

5. Trigeminal Neuralgia;Neurologic Clinics;2023-02